CONMED Corporation (CNMD)

Currency in USD
41.56
-0.06(-0.14%)
Closed·
41.560.00(0.00%)
·
Earnings results expected in 6 days
CNMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
41.1442.64
52 wk Range
38.3274.70
Key Statistics
Prev. Close
41.62
Open
41.77
Day's Range
41.14-42.64
52 wk Range
38.32-74.7
Volume
492.56K
Average Volume (3m)
566.01K
1-Year Change
-41.4648%
Book Value / Share
32.57
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
48.40
Upside
+16.46%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

CONMED Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

CONMED Corporation Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

CONMED Corporation Earnings Call Summary for Q3/2025

  • CONMED reported Q3 2025 adjusted EPS of $1.08 (beating $1.05 forecast) and revenue of $338 million (up 6.7% YoY), despite stock closing down 2.78% at $44.44.
  • The company announced a $150 million share repurchase program while maintaining full-year revenue guidance of $1.365-1.372 billion and adjusted EPS of $4.48-4.53.
  • Q4 2025 revenue is projected between $363-370 million, with management highlighting strategic product evaluation focused on long-term return on invested capital.
  • Growth was driven by expansion in BioBrace and AirSeal platforms, improved orthopedic supply chain efficiency, and record manufacturing volumes.
  • Despite positive earnings, the stock trades near its 52-week low of $42.50, significantly below fair value according to InvestingPro data, suggesting potential undervaluation.
Last Updated: 2025-11-05, 05:24 p/m
Read Full Transcript

Compare CNMD to Peers and Sector

Metrics to compare
CNMD
Peers
Sector
Relationship
P/E Ratio
20.1x35.8x−0.6x
PEG Ratio
−0.390.330.00
Price/Book
1.3x3.5x2.6x
Price / LTM Sales
1.0x3.4x3.4x
Upside (Analyst Target)
22.5%87.5%42.5%
Fair Value Upside
Unlock22.8%5.8%Unlock

Analyst Ratings

1 Buy
5 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 48.40
(+16.46% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Hold47.00+13.09%57.00MaintainNov 06, 2025
Piper Sandler
Buy55.00+32.34%68.00MaintainNov 06, 2025
JPMorgan
Hold52.00+25.12%58.00MaintainNov 06, 2025
Needham
Hold---MaintainNov 06, 2025
Piper Sandler
Buy68.00+63.62%80.00MaintainJul 31, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.05%
Dividend Yield
1.92%
Industry Median 1.42%
Annualized payout
0.80
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
1.08 / 1.05
Revenue / Forecast
337.90M / 334.71M
EPS Revisions
Last 90 days

CNMD Income Statement

People Also Watch

36.69
HRMY
+2.17%
28.09
BRBR
+4.89%
45.22
SHOO
+1.50%
21.18
SMPL
+0.81%
14.33
ACHC
+0.63%

FAQ

What Is the CONMED (CNMD) Stock Price Today?

The CONMED stock price today is 41.56

What Stock Exchange Does CONMED Trade On?

CONMED is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for CONMED?

The stock symbol for CONMED is "CNMD."

Does CONMED Pay Dividends? What’s The Current Dividend Yield?

The CONMED dividend yield is 1.92%.

What Is the CONMED Market Cap?

As of today, CONMED market cap is 1.29B.

What Is CONMED's Earnings Per Share (TTM)?

The CONMED EPS (TTM) is 2.05.

When Is the Next CONMED Earnings Date?

CONMED will release its next earnings report on Jan 28, 2026.

From a Technical Analysis Perspective, Is CNMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CONMED Stock Split?

CONMED has split 3 times.

How Many Employees Does CONMED Have?

CONMED has 3900 employees.

What is the current trading status of CONMED (CNMD)?

As of Jan 22, 2026, CONMED (CNMD) is trading at a price of 41.56, with a previous close of 41.62. The stock has fluctuated within a day range of 41.14 to 42.64, while its 52-week range spans from 38.32 to 74.70.

What Is CONMED (CNMD) Price Target According to Analysts?

The average 12-month price target for CONMED is USD48.40, with a high estimate of USD55 and a low estimate of USD41. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +16.46% Upside potential.

What Is the CNMD Premarket Price?

CNMD's last pre-market stock price is 40.65. The pre-market share volume is 20.00, and the stock has decreased by -0.97, or -2.33%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.